title: Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.
authors.affiliation: Division of Neurosurgery, Preston Robert Tisch Brain Tumor Center, Duke University School of Medicine, Durham, North Carolina (G.V., P.E.F., J.H.S.); Dana-Farber Cancer Institute and Harvard University School of Medicine, Boston, Massachusetts (D.R.).
authors.forename: Gordana
authors.initials: G
authors.lastname: Vlahovic
authors.affiliation: Division of Neurosurgery, Preston Robert Tisch Brain Tumor Center, Duke University School of Medicine, Durham, North Carolina (G.V., P.E.F., J.H.S.); Dana-Farber Cancer Institute and Harvard University School of Medicine, Boston, Massachusetts (D.R.).
authors.forename: Peter E
authors.initials: PE
authors.lastname: Fecci
authors.affiliation: Division of Neurosurgery, Preston Robert Tisch Brain Tumor Center, Duke University School of Medicine, Durham, North Carolina (G.V., P.E.F., J.H.S.); Dana-Farber Cancer Institute and Harvard University School of Medicine, Boston, Massachusetts (D.R.).
authors.forename: David
authors.initials: D
authors.lastname: Reardon
authors.affiliation: Division of Neurosurgery, Preston Robert Tisch Brain Tumor Center, Duke University School of Medicine, Durham, North Carolina (G.V., P.E.F., J.H.S.); Dana-Farber Cancer Institute and Harvard University School of Medicine, Boston, Massachusetts (D.R.).
authors.forename: John H
authors.initials: JH
authors.lastname: Sampson
mesh_terms: D060890:B7-H1 Antigen / Q000378:metabolism*; D001932:Brain Neoplasms / Q000378:metabolism*; D005909:Glioblastoma / Q000378:metabolism*; D006801:Humans; D016246:Lymphocytes, Tumor-Infiltrating / Q000378:metabolism*
chemical_list: D060890:B7-H1 Antigen